Despite the relative paucity of peer-reviewed studies for IVDs in general, several companies are taking steps to publish their data, which can ultimately lead to positive coverage decisions by payers
The text messaging kerfuffle at CMS reflects the changes in the Joint Commission's text messaging policy in the past few years.
23andMe's weight loss study reflects the company's push to refine genomic tests by identifying genetic determinants of various diseases and chronic conditions. The study also dovetails with other companies that want to take on the country's weight management challenge with genetic testing.
For Republicans, All Black Vote Is ‘Fraud’ Above The Law Silk Road Administrator Appeals Case Before Supreme Court How Appealing The [Dumb] Year In Bitcoin Dealbreaker Partnership For A Reliable Energy Future Breaking Energy
Peter Meath, Managing Director and Head of Life Sciences for J.P. Morgan’s Commercial Banking business, shared his perspective on what will happen in the biopharma industry in 2018.
Evan Greebel acted as outside counsel for pharma company Retrophin from 2012 to 2014. Prosecutors alleged during that time Greebel assisted Martin Shkreli in using Retrophin’s assets to pay investors in unrelated hedge funds run by Shkreli through the use of phony settlement and consulting agreements.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Busy Burr leads the innovation team in Palo Alto for Humana. In an expansive phone interview, she talks about parallels between improv and innovation, what true partnership means and where Humana is looking to change healthcare.
The Friend Zone And Sexual Harassment Above The Law Is The Supreme Court Backsliding on LGBT Rights? Two And A Half Years After It Sanctioned Gay Marriage, The Court Has Been Sowing Confusion About Its Commitment To Equal Citizenship How Appealing Judge Dies In Peace After Owning Argentina Dealbreaker Five Things To Watch As Industry Tackles Methane In 2018 Breaking Energy
Studies have shown that the absence of professional interpreters can increase a patient’s length of stay in a hospital, and increase readmission rates.
The Center for Connected Health Policy has unveiled a list of telehealth legislation approved in 2017. Here's a closer look at the 11 pieces of legislation in nine states that will take effect in 2018.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Remember The Pentagon Papers Case? Because Steven Spielberg Doesn’t Above The Law Military Poised To Accept Transgender Troops, Despite Trump Tweets, As Courts Block Ban How Appealing Swiss Person To Keep JPMorgan From Getting Too Swiss Again Dealbreaker Israel’s Gas Disappointment Breaking Energy
In a recent phone interview, Geisinger President and CEO Dr. David Feinberg chatted about his organization's recent National Symposium, its National Precision Health Initiative and what's on the horizon in 2018.
Companies that leverage AI can leapfrog antiquated players with data that can do everything from coach a person about which exercise regimen has the biggest impact on their health outcomes to which medicine a clinician should prescribe to a specific patient.
The Tel Aviv, Israel-based startup is leveraging artificial intelligence and deep learning to improve the radiology workflow. Its technology pinpoints abnormalities in a medical image.
Woman Complains About Male-Dominated Panel, Gets Booted Off Panel Above The Law American ISIS Suspect Held In Iraq Has Right To Lawyer, Judge Rules How Appealing Goldman Sachs Shows Up A Day Late And Way Short To The Bitcoin Party Dealbreaker New Jersey’s Considering A Nuclear Bailout – Here’s Why We Don’t Need It Breaking Energy
